IRB Fee
An important initiative has been under way to increase the volume of clinical research studies at UTHSC. In order to facilitate the process of administrative review, the IRB has expanded its facilities, staff and services. A critical component of the new services has involved the development of iMedRIS, the IRB electronic system. The implementation of iMedRIS has helped to reduce the review cycle and is eliminating the use of paper in the review process. To offset the additional administrative costs associated with the expansion and maintenance of this sophisticated electronic system, the UTHSC IRB is revising the fee schedule for all industry sponsored study submissions requiring full board, expedited and exempt review effective July 1, 2009.
Refer to the table below for comparing previous and updated IRB fees. The updated fees apply only to trials supported by pharmaceutical firms and other for-profit entities that are submitted on or after July 1, 2009. Research applications submitted between July 1, 2008 and June 30, 2009 will follow the appropriate fee schedule and all research projects that were submitted on or prior to June 30, 2008 will continue to follow the fee schedule of a one-time global IRB fee. There will continue to be no charge for federal, foundation, investigator-initiated, or university supported research. The new IRB fees have been given careful consideration and are consistent with fees charged at other universities.
Payment of IRB fees is regarded as a contractual responsibility of the sponsor. The fees are assessments of actual costs associated with protocol review by the IRB and are charged for services rendered. Because the IRB commits its full resources to each review, the fees are due in full from the sponsor, even if the IRB does not approve the study, subjects are never enrolled, or the study is terminated before objectives are reached.
For questions, contact the UTHSC IRB office at 448-4824.
University of Tennessee Health Science Center
Institutional Review Board
Previous and Updated Review Charges for Trials Supported by Pharmaceutical Firms and Other For-Profit Entities
IRB Review Category |
Fee for Studies submitted on or prior to June 30, 2008 |
Fee for Studies submitted from July 1, 2008 through June 30, 2009 |
Fees for Studies submitted on or after July 1, 2009 |
| Full Board Review* | $1,800 |
$2,000 |
$2,400 |
| Expedited Review* | No charge |
$1,000 |
$1,200 |
| Exempt Status* | No charge |
$500 |
$500 |
| Annual Reviews | No charge |
$250 |
$500 |
| Revisions* | |||
| Major Changes (full board review) |
No charge |
$500 |
$500 |
| Minor changes (expedited review) |
No charge |
No charge |
No charge |
| Recruitment Materials | No charge |
No charge |
No charge |
| Adverse Events | No charge |
No charge |
No charge |
| *Appropriateness of review category determined by the IRB office | |||
Search UTHSC Research
Research Quick Links
Research Partners
Contact Us
UTHSC IRB office
910 Madison
Suite 600
Memphis, TN 38163
Phone: (901) 448-4824
